ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Valneva Se

Valneva Se (0OB3)

3.455
0.00
(0.00%)
Closed January 05 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
3.455
Bid
3.37
Ask
3.54
Volume
50,724
0.00 Day's Range 0.00
3.455 52 Week Range 3.455
Market Cap
Previous Close
3.455
Open
-
Last Trade
43
@
2.252
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
28,411
Shares Outstanding
138,912,000
Dividend Yield
-
PE Ratio
-3.08
Earnings Per Share (EPS)
-0.73
Revenue
175.73M
Net Profit
-101.43M

About Valneva Se

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Saint-herblain, Loire-atlantique, Fra
Founded
-
Valneva Se is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0OB3. The last closing price for Valneva was 3.46 €. Over the last year, Valneva shares have traded in a share price range of 3.455 € to 3.455 €.

Valneva currently has 138,912,000 shares outstanding. The market capitalization of Valneva is 479.94 € million. Valneva has a price to earnings ratio (PE ratio) of -3.08.

0OB3 Latest News

VALNEVA Déclaration d’actions et de droits de vote : 31 décembre 2024

VALNEVA Déclaration d’actions et de droits de vote : 31 décembre 2024 VALNEVA Déclaration d’actions et de droits de vote 31 décembre 2024__________________________________________________________...

VALNEVA Declaration of shares and voting rights: December 31, 2024

VALNEVA Declaration of shares and voting rights: December 31, 2024 VALNEVA Declaration of shares and voting rights December 31, 2024_______________________________________________________________...

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India Saint-Herblain (France), Pune, (India), December 19, 2024 – Valneva SE (“Valneva” or “the...

Valneva accroît l’accessibilité de son vaccin contre le chikungunya en Asie grâce à une collaboration avec le Serum Institute of India

Valneva accroît l’accessibilité de son vaccin contre le chikungunya en Asie grâce à une collaboration avec le Serum Institute of India Saint-Herblain (France), Pune, (Inde), le 19 décembre 2024 –...

Déclaration d'actions et de droits de vote de la société Valneva SE - novembre 2024

Déclaration d'actions et de droits de vote de la société Valneva SE - novembre 2024 VALNEVA Déclaration d’actions et de droits de vote 30 novembre 2024________________________________________...

VALNEVA - Declaration of shares and voting rights: November 30, 2024

VALNEVA - Declaration of shares and voting rights: November 30, 2024 VALNEVA Declaration of shares and voting rights November 30, 2024______________________________________________________________...

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal Saint-Herblain (France), December 4, 2024 – Valneva SE (Nasdaq:...

Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya

Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya Saint-Herblain (France), le 4 décembre 2024 – Valneva SE...

Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ®

Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ® Les niveaux d’anticorps demeurent élevés avec un...

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® Antibody levels remained high at 96% seroresponse in line with the two-year...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.4553.4553.455359533.455DE
4003.4553.4553.455309203.455DE
12003.4553.4553.455284113.455DE
26003.4553.4553.455357643.455DE
52003.4553.4553.455347203.455DE
156003.4553.4553.455379213.455DE
260003.4553.4553.455374423.455DE

0OB3 - Frequently Asked Questions (FAQ)

What is the current Valneva share price?
The current share price of Valneva is 3.455 €
How many Valneva shares are in issue?
Valneva has 138,912,000 shares in issue
What is the market cap of Valneva?
The market capitalisation of Valneva is EUR 479.94M
What is the 1 year trading range for Valneva share price?
Valneva has traded in the range of 3.455 € to 3.455 € during the past year
What is the PE ratio of Valneva?
The price to earnings ratio of Valneva is -3.08
What is the cash to sales ratio of Valneva?
The cash to sales ratio of Valneva is 1.78
What is the reporting currency for Valneva?
Valneva reports financial results in EUR
What is the latest annual turnover for Valneva?
The latest annual turnover of Valneva is EUR 175.73M
What is the latest annual profit for Valneva?
The latest annual profit of Valneva is EUR -101.43M
What is the registered address of Valneva?
The registered address for Valneva is 6 RUE ALAIN BOMBARD, CAMPUS BIO-OUEST, SAINT-HERBLAIN, LOIRE-ATLANTIQUE, 44800
What is the Valneva website address?
The website address for Valneva is www.valneva.com
Which industry sector does Valneva operate in?
Valneva operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
crescentmotor crescentmotor 2 minutes ago
But in the case of Blarcamisine, "sufficient" efficacy is up for debate (given the known data).

Granted, the efficacy of Blarcamesine is still under study but, with the favorable peer review, the winds look favorable. And then what else? There's the safety question where Blarcamesi
AVXL
benz280c benz280c 2 minutes ago
Incorrect and reviling. Do better, please, in 2025.
GDVM
3331 3331 2 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
IHuser IHuser 3 minutes ago
imo... easier to ban my narrative than counter it........ never going away AZN


AZN



IHuser
AZN
3331 3331 3 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
harry crumb harry crumb 3 minutes ago
Oh you are from china an part of this scam,you will go down with ILLR when the SEC investigates the fraud of this company
ILLR
martyDg martyDg 3 minutes ago
Damn, I'mma put you now on my ignore list... I'm tired of seeing you stupid conspiracy theories. Effing clown.
NWBO
BDEZ BDEZ 4 minutes ago
“Everything the government says is a lie, and everything it has is stolen” ~ Nietzsche
harry crumb harry crumb 6 minutes ago
There is no desmis you moron fool! Stop lying. Tiktok is #1 an always will be, how can you lie, your mother must keep you in a closet all day with your noony in your mouth you fool
ILLR
stockinspector stockinspector 6 minutes ago
Dad'burn delightful display of doubtful detractors denying, debating and delirious!
WDLF
gawti88 gawti88 6 minutes ago
I wish you were in this riding with us, unfortunately your crew decided to short it for years and you're going to feel the pain now. When we hit 25c, I hope you don't cry.
CEOS
gawti88 gawti88 7 minutes ago
Wait; small company? lmao... dang 95 + employees isn't a small company.
CEOS
JERSEYHAWG JERSEYHAWG 8 minutes ago
Listen to this bro.
I am on no email lists and don't send email lists to anyone. Why? Cause I don't give a Flynn fuk.

That email, of stuff you said you wrote, and I believe it was sent to me. On a rare occasion zi get something sent to me. For instance this time. I don't mess
LEHNQ
jimr1717 jimr1717 8 minutes ago
This blatant scam is done
ILLR
nowwhat2 nowwhat2 10 minutes ago
Why no be just keep go up yet ?

.
XRPUSD
StayHumble StayHumble 10 minutes ago
w0w SEC🔥catches🎅🏿&👽ArtificiallyDeflating Prices 2Buy Shares"


6, 12, 2023 —

SEC charged investment adviser Sabby Management LLC & managing partner,Hal D. Mintz,w/ fraud in connection w/ a long running scheme involving misrepresenta
HMBL
elks elks 12 minutes ago
Wtf.
TWOH
fuagf fuagf 13 minutes ago
Security risk? Shrug. Trump flips on Tik Tok, because it's good for him.

PatriotTakes 🇺🇸
@patriottakes
Nikki Haley comes out against Trump’s plan to save TikTok, but won’t mention him by name

https://pbs.twimg.com/media/GgeV_fjXkAAgNe7?form
XMaster2023 XMaster2023 15 minutes ago
Roman, there could already be deals cut and the only thing we are waiting for now is approval. I actually believe this is the case and NWBO is under a gag order as BP would not want anything getting out until approval.
NWBO
JJ8 JJ8 17 minutes ago
I am encouraged of what I see of the Histogram in the Weekly Chart showing that a new uptrend appears to be in the process of developing for the AMD share price.

Hopefully that is going to continue... and lead to a share price breakout soon.

We shall see.
AMD
boi568 boi568 18 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months. They may also have understandably diverted some resources towards a successful MAA.
AVXL
boi568 boi568 20 minutes ago
There is no regulatory "sufficiency" test, other than being better than the standard of care, if one exists. The article makes the case that blarcamesine is better than any approved AD drug. The FDA employs a risk/benefit analysis, and you want your drug candidate to more than offset any risks with
AVXL
benz280c benz280c 20 minutes ago
Changing the innards of a Chevy with Ferrari parts is a game changer. Learn about the Z06. Maybe you will appreciate what is set to occur when the cusip, name, and ticker changes in this instance. Ignorance is alive and well by folks old enough to know better. Sad!
https://www.detroitnews.com
GDVM

Your Recent History

Delayed Upgrade Clock